Emma Wallace
Auto-generated profile, based on publicly available information

Emma Wallace

Department of General Practice, School of Medicine, University College Cork, Cork, Ireland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2015 in BMJ
Verified
Journal Article
Closed access
PDF file
EWEmma Wallace
Emma Wallace
CSChris Salisbury
Chris Salisbury
BGBruce Guthrie
Bruce Guthrie
CLCliona Lewis
Cliona Lewis
TFTom Fahey
Tom Fahey
SSSusan M Smith
Susan M Smith

15 March 2016 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
SSSusan M Smith
Susan M Smith
EWEmma Wallace
Emma Wallace
TOTom O'Dowd
Tom O'Dowd
MFMartin Fortin
Martin Fortin

15 October 2015 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
ARAine Ryan
Aine Ryan
EWEmma Wallace
Emma Wallace
POPaul O’hara
Paul O’hara
SSSusan M. Smith
Susan M. Smith
Health and Quality of Life Outcomes is an open access, peer-reviewed, online journal offering high quality articles, rapid publication and wide diffusion in ...

20 October 2021 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
SSSusan M. Smith
Susan M. Smith
EWEmma Wallace
Emma Wallace
BCBarbara Clyne
Barbara Clyne
FBFiona Boland
Fiona Boland
MFMartin Fortin
Martin Fortin
Background: Multimorbidity, defined as the co-existence of two or more chronic conditions, presents significant challenges to patients, healthcare providers and health systems. Despite this, there is ongoing uncertainty about the most effective ways to manage patients with multimorbidity. This review updated and narrowed the focus of a previous Cochrane review and aimed to determine the effectiveness of interventions designed to improve outcomes in people with multimorbidity in primary care and community settings, compared to usual care.Methods: We searched eight databases and two trials registers up to 9 September 2019. Two review authors independently screened potentially eligible titles and selected studies, extracted data, evaluated study quality and judged the certainty of the evidence (GRADE). Interventions were grouped by their predominant focus into care-coordination/self-management support, self-management support and medicines management. Main outcomes were health-related quality of life (HRQoL) and mental health. Meta-analyses were conducted, where possible, but the synthesis was predominantly narrative.Results: We included 16 RCTs with 4753 participants, the majority being older adults with at least three conditions. There were eight care-coordination/self-management support studies, four self-management support studies and four medicines management studies. There was little or no evidence of an effect on primary outcomes of HRQoL (MD 0.03, 95% CI −0.01 to 0.07,I2= 39%) and mental health or on secondary outcomes with a small number of studies reporting that care coordination may improve patient experience of care and self-management support may improve patient health behaviours. Overall, the certainty of the evidence was graded as low due to significant variation in study participants and interventions.Conclusions: There are remaining uncertainties about the effectiveness of interventions for people with multimorbidity, despite the growing number of RCTs conducted in this area. Our findings suggest that future research should consider patient experience of care, optimising medicines management and targeted patient health behaviours such as exercise.

14 May 2019 in BMJ
Verified
Journal Article
Closed access
PDF file
GBG E Bekkering
G E Bekkering
TAT Agoritsas
T Agoritsas
LLL Lytvyn
L Lytvyn
AHA F Heen
A F Heen
MFM Feller
M Feller
MVM Vermandere
M Vermandere
Clinical question What are the benefits and harms of thyroid hormones for adults with subclinical hypothyroidism (SCH)? This guideline was triggered by a recent systematic review of randomised controlled trials, which could alter practice. Current practice Current guidelines tend to recommend thyroid hormones for adults with thyroid stimulating hormone (TSH) levels >10 mIU/L and for people with lower TSH values who are young, symptomatic, or have specific indications for prescribing. Recommendation The guideline panel issues a strong recommendation against thyroid hormones in adults with SCH (elevated TSH levels and normal free T4 (thyroxine) levels). It does not apply to women who are trying to become pregnant or patients with TSH >20 mIU/L. It may not apply to patients with severe symptoms or young adults (such as those ≤30 years old). How this guideline was created A guideline panel including patients, clinicians, and methodologists produced this recommendation in adherence with standards for trustworthy guidelines using the GRADE approach. The evidence The systematic review included 21 trials with 2192 participants. For adults with SCH, thyroid hormones consistently demonstrate no clinically relevant benefits for quality of life or thyroid related symptoms, including depressive symptoms, fatigue, and body mass index (moderate to high quality evidence). Thyroid hormones may have little or no effect on cardiovascular events or mortality (low quality evidence), but harms were measured in only one trial with few events at two years’ follow-up. Understanding the recommendation The panel concluded that almost all adults with SCH would not benefit from treatment with thyroid hormones. Other factors in the strong recommendation include the burden of lifelong management and uncertainty on potential harms. Instead, clinicians should monitor the progression or resolution of the thyroid dysfunction in these adults. Recommendations are made actionable for clinicians and their patients through visual overviews. These provide the relative and absolute benefits and harms of thyroid hormones in multilayered evidence summaries and decision aids available in MAGIC (https://app.magicapp.org/) to support shared decisions and adaptation of this guideline.

12 March 2018 in The Annals of Family Medicine
Verified
Journal Article
Closed access
PDF file
SSSusan M. Smith
Susan M. Smith
EWEmma Wallace
Emma Wallace
CSChris Salisbury
Chris Salisbury
MSMaxime Sasseville
Maxime Sasseville
EBElizabeth Bayliss
Elizabeth Bayliss
MFMartin Fortin
Martin Fortin
PURPOSE We aimed to develop a consensus-based set of core outcomes specifically for studies in multimorbidity. METHODS We undertook a consensus study following the COS-STAR (Core Outcome Set-STAndards for Reporting) guidelines for the design and reporting of core outcome sets. A Delphi panel of experts completed a web-based survey with 2 rounds. Panelists were presented with a range of outcomes that had been identified in previous workshops and a related systematic review. They indicated their level of agreement on whether each outcome should be included in the core set using a 5-point Likert scale, and outcomes reaching a prespecified consensus level were included. RESULTS Of 30 individuals invited to be panelists, 26 from 13 countries agreed. All 26 completed both rounds of the survey. The Delphi panel reached consensus on 17 outcomes for inclusion in a core outcome set for multimorbidity (COSmm). The highest-ranked outcomes were health-related quality of life, mental health outcomes, and mortality. Other outcomes were grouped into overarching themes of patient-reported impacts and behaviors (treatment burden, self-rated health, self-management behavior, self-efficacy, adherence); physical activity and function (activities of daily living, physical function, physical activity); consultation related (communication, shared decision making, prioritization); and health systems (health care use, costs, quality of health care). CONCLUSIONS This consensus study involved a wide range of international experts who identified a large number of outcomes for multimorbidity intervention studies. Our results suggest that quality of life, mental health outcomes, and mortality should be regarded as essential core outcomes. Researchers should, however, also consider the full range of outcomes when designing studies to capture important domains in multimorbidity depending on individual study aims and interventions.